Home  ||| S:0 E:5 ||| RB
hospice  ||| S:5 E:13 ||| JJ
care  ||| S:13 E:18 ||| NN
for  ||| S:18 E:22 ||| IN
the  ||| S:22 E:26 ||| DT
urological  ||| S:26 E:37 ||| JJ
cancer  ||| S:37 E:44 ||| NN
patients  ||| S:44 E:53 ||| NNS
In  ||| S:53 E:56 ||| IN
order  ||| S:56 E:62 ||| NN
to  ||| S:62 E:65 ||| TO
clarify  ||| S:65 E:73 ||| VB
the  ||| S:73 E:77 ||| DT
clinical  ||| S:77 E:86 ||| JJ
characteristics  ||| S:86 E:102 ||| NNS
along  ||| S:102 E:108 ||| IN
with  ||| S:108 E:113 ||| IN
practical  ||| S:113 E:123 ||| JJ
care  ||| S:123 E:128 ||| NN
of  ||| S:128 E:131 ||| IN
home  ||| S:131 E:136 ||| NN
hospice  ||| S:136 E:144 ||| NN
care  ||| S:144 E:149 ||| NN
for  ||| S:149 E:153 ||| IN
urological  ||| S:153 E:164 ||| JJ
cancer  ||| S:164 E:171 ||| NN
patients ||| S:171 E:179 ||| NNS
,  ||| S:179 E:181 ||| ,
we  ||| S:181 E:184 ||| PRP
analyzed  ||| S:184 E:193 ||| VBD
62  ||| S:193 E:196 ||| CD
terminal  ||| S:196 E:205 ||| NN
ill  ||| S:205 E:209 ||| RB
urological  ||| S:209 E:220 ||| JJ
cancer  ||| S:220 E:227 ||| NN
patients  ||| S:227 E:236 ||| NNS
who  ||| S:236 E:240 ||| WP
died  ||| S:240 E:245 ||| VBD
at  ||| S:245 E:248 ||| IN
home ||| S:248 E:252 ||| NN
,  ||| S:252 E:254 ||| ,
and  ||| S:254 E:258 ||| CC
these  ||| S:258 E:264 ||| DT
patients  ||| S:264 E:273 ||| NNS
were  ||| S:273 E:278 ||| VBD
compared  ||| S:278 E:287 ||| VBN
with  ||| S:287 E:292 ||| IN
737  ||| S:292 E:296 ||| CD
non-urological  ||| S:296 E:311 ||| JJ
cancer  ||| S:311 E:318 ||| NN
patients  ||| S:318 E:327 ||| NNS
in  ||| S:327 E:330 ||| IN
the  ||| S:330 E:334 ||| DT
period  ||| S:334 E:341 ||| NN
from  ||| S:341 E:346 ||| IN
July  ||| S:346 E:351 ||| NNP
2003  ||| S:351 E:356 ||| CD
through  ||| S:356 E:364 ||| IN
June  ||| S:364 E:369 ||| NNP
2010 ||| S:369 E:373 ||| CD
.  ||| S:373 E:375 ||| .
There  ||| S:375 E:381 ||| EX
was  ||| S:381 E:385 ||| VBD
a  ||| S:385 E:387 ||| DT
tendency  ||| S:387 E:396 ||| NN
to  ||| S:396 E:399 ||| TO
have  ||| S:399 E:404 ||| VB
a  ||| S:404 E:406 ||| DT
longer  ||| S:406 E:413 ||| RBR
homecare  ||| S:413 E:422 ||| JJ
period  ||| S:422 E:429 ||| NN
for  ||| S:429 E:433 ||| IN
urological  ||| S:433 E:444 ||| JJ
terminal  ||| S:444 E:453 ||| NN
cancer  ||| S:453 E:460 ||| NN
patients ||| S:460 E:468 ||| NNS
.  ||| S:468 E:470 ||| .
However ||| S:470 E:477 ||| RB
,  ||| S:477 E:479 ||| ,
no  ||| S:479 E:482 ||| DT
significant  ||| S:482 E:494 ||| JJ
statistical  ||| S:494 E:506 ||| JJ
differences  ||| S:506 E:518 ||| NNS
in  ||| S:518 E:521 ||| IN
age ||| S:521 E:524 ||| NN
,  ||| S:524 E:526 ||| ,
gender  ||| S:526 E:533 ||| NN
and  ||| S:533 E:537 ||| CC
a  ||| S:537 E:539 ||| DT
frequency  ||| S:539 E:549 ||| NN
of  ||| S:549 E:552 ||| IN
home  ||| S:552 E:557 ||| NN
death  ||| S:557 E:563 ||| NN
were  ||| S:563 E:568 ||| VBD
observed  ||| S:568 E:577 ||| VBN
among  ||| S:577 E:583 ||| IN
the  ||| S:583 E:587 ||| DT
urological  ||| S:587 E:598 ||| NN
and  ||| S:598 E:602 ||| CC
non-urological  ||| S:602 E:617 ||| JJ
cancer  ||| S:617 E:624 ||| NN
patients ||| S:624 E:632 ||| NNS
.  ||| S:632 E:634 ||| .
The  ||| S:634 E:638 ||| DT
frequency  ||| S:638 E:648 ||| NN
of  ||| S:648 E:651 ||| IN
medical  ||| S:651 E:659 ||| JJ
treatments  ||| S:659 E:670 ||| NNS
for  ||| S:670 E:674 ||| IN
urological  ||| S:674 E:685 ||| JJ
cancer  ||| S:685 E:692 ||| NN
patients ||| S:692 E:700 ||| NNS
,  ||| S:700 E:702 ||| ,
such  ||| S:702 E:707 ||| JJ
as  ||| S:707 E:710 ||| IN
home  ||| S:710 E:715 ||| NN
oxygen  ||| S:715 E:722 ||| NN
therapy ||| S:722 E:729 ||| NN
,  ||| S:729 E:731 ||| ,
management  ||| S:731 E:742 ||| NN
of  ||| S:742 E:745 ||| IN
nephrostomy  ||| S:745 E:757 ||| NN
and  ||| S:757 E:761 ||| CC
a  ||| S:761 E:763 ||| DT
placement  ||| S:763 E:773 ||| NN
of  ||| S:773 E:776 ||| IN
indwelling  ||| S:776 E:787 ||| JJ
bladder  ||| S:787 E:795 ||| NN
catheter ||| S:795 E:803 ||| NN
,  ||| S:803 E:805 ||| ,
was  ||| S:805 E:809 ||| VBD
much  ||| S:809 E:814 ||| RB
higher  ||| S:814 E:821 ||| JJR
for  ||| S:821 E:825 ||| IN
the  ||| S:825 E:829 ||| DT
urological  ||| S:829 E:840 ||| JJ
cancer  ||| S:840 E:847 ||| NN
patients ||| S:847 E:855 ||| NNS
.  ||| S:855 E:857 ||| .
On  ||| S:857 E:860 ||| IN
the  ||| S:860 E:864 ||| DT
other  ||| S:864 E:870 ||| JJ
hand ||| S:870 E:874 ||| NN
,  ||| S:874 E:876 ||| ,
there  ||| S:876 E:882 ||| EX
was  ||| S:882 E:886 ||| VBD
no  ||| S:886 E:889 ||| DT
big  ||| S:889 E:893 ||| JJ
difference  ||| S:893 E:904 ||| NN
for  ||| S:904 E:908 ||| IN
consumption  ||| S:908 E:920 ||| NN
of  ||| S:920 E:923 ||| IN
strong  ||| S:923 E:930 ||| JJ
opioid  ||| S:930 E:937 ||| JJ
usage  ||| S:937 E:943 ||| NN
among  ||| S:943 E:949 ||| IN
the  ||| S:949 E:953 ||| DT
urological  ||| S:953 E:964 ||| NN
and  ||| S:964 E:968 ||| CC
non-urological  ||| S:968 E:983 ||| JJ
cancer  ||| S:983 E:990 ||| NN
patients ||| S:990 E:998 ||| NNS
.  ||| S:998 E:1000 ||| .
In  ||| S:1000 E:1003 ||| IN
conclusion ||| S:1003 E:1013 ||| NN
,  ||| S:1013 E:1015 ||| ,
although  ||| S:1015 E:1024 ||| IN
ordinary  ||| S:1024 E:1033 ||| JJ
medical  ||| S:1033 E:1041 ||| JJ
treatments  ||| S:1041 E:1052 ||| NNS
for  ||| S:1052 E:1056 ||| IN
urological  ||| S:1056 E:1067 ||| JJ
cancer  ||| S:1067 E:1074 ||| NN
patients  ||| S:1074 E:1083 ||| NNS
showed  ||| S:1083 E:1090 ||| VBD
no  ||| S:1090 E:1093 ||| DT
significant  ||| S:1093 E:1105 ||| JJ
differences  ||| S:1105 E:1117 ||| NNS
compared  ||| S:1117 E:1126 ||| VBN
with  ||| S:1126 E:1131 ||| IN
non-urological  ||| S:1131 E:1146 ||| JJ
cancer  ||| S:1146 E:1153 ||| NN
patients ||| S:1153 E:1161 ||| NNS
,  ||| S:1161 E:1163 ||| ,
professional  ||| S:1163 E:1176 ||| JJ
special  ||| S:1176 E:1184 ||| JJ
assistance  ||| S:1184 E:1195 ||| NN
such  ||| S:1195 E:1200 ||| JJ
as  ||| S:1200 E:1203 ||| IN
a  ||| S:1203 E:1205 ||| DT
change  ||| S:1205 E:1212 ||| NN
of  ||| S:1212 E:1215 ||| IN
the  ||| S:1215 E:1219 ||| DT
nephrostomy  ||| S:1219 E:1231 ||| JJ
catheter  ||| S:1231 E:1240 ||| NN
were  ||| S:1240 E:1245 ||| VBD
required  ||| S:1245 E:1254 ||| VBN
for  ||| S:1254 E:1258 ||| IN
urological  ||| S:1258 E:1269 ||| JJ
cancer  ||| S:1269 E:1276 ||| NN
patients ||| S:1276 E:1284 ||| NNS
.  ||| S:1284 E:1286 ||| .
